Alpine Associates Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Alpine Associates Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,116,800	Closed	-$98.3M	–	50
2023 Q2	$98.3M	Buy	+2,116,800	New	+$73.2M	4.43%	9

Alpine Associates Management's DICE Position: Q3 2023 in Review

Alpine Associates Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,116,800 shares — an estimated $98.3M sold.

Alpine Associates Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $98.3M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Alpine Associates Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Alpine Associates Management sold 2,116,800 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $98.3M.
Alpine Associates Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Alpine Associates Management's DICE Therapeutics, Inc. Common Stock position peaked at $98.3M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Alpine Associates Management's 13F filing for Q3 2023, filed 8 Nov 2023.